About Mustang Bio (MBIO)
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The Company... Read more
- USD1.30
- USD1.36
- USD1.16
- USD65.00
- -5.00%
- 17.91M
- 90.54k
- 3M
- 1.13
- -92.60%
Stock News
4 hours ago
Prosus: Best Proxy To Internet Giant Tencent
SeekingAlpha
4 hours ago
Alphabet’s blowout earnings may mark the peak for this year — but the stock’s still a good buy
MarketWatch
yesterday
Alphabet expects 'slight headwind' to ads business this year, executives say
CNBC
yesterday
Jim Cramer credits this week's rally to earnings and restraint from the White House
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
